These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


276 related items for PubMed ID: 9222412

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Temporal effects of estradiol and diethylstilbestrol on pituitary and plasma prolactin levels in ovariectomized Fischer 344 and Holtzman rats: a comparison of radioimmunoassay and Nb2 lymphoma cell bioassay.
    Moy J, Lawson D.
    Proc Soc Exp Biol Med; 1992 Sep; 200(4):507-13. PubMed ID: 1508941
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fischer 344 rats.
    Elias KA, Weiner RI.
    Endocrinology; 1987 Feb; 120(2):617-21. PubMed ID: 3803294
    [Abstract] [Full Text] [Related]

  • 25. Dopaminergic regulation of the estrogen-induced glandular kallikrein in the rat anterior pituitary.
    Powers CA, Hatala MA.
    Neuroendocrinology; 1986 Feb; 44(4):462-9. PubMed ID: 3029615
    [Abstract] [Full Text] [Related]

  • 26. Effects of Neonatal Exposure to Estradiol on Prolactin Secretion and Activity of the Tubero-lnfundibular Dopamine System in Young Adulthood: Comparison with Neonatal Prolactin Deficiency*.
    Crowley WR, Shah GV, Watanobe H, Grosvenor CE.
    J Neuroendocrinol; 1990 Feb 01; 2(1):19-24. PubMed ID: 19210392
    [Abstract] [Full Text] [Related]

  • 27. Hyperprolactinemia attenuates ovarian steroid stimulation of region-specific hypothalamic serotonin synthesis and luteinizing hormone release in ovariectomized rats.
    King TS, Carrillo AJ, Morgan WW.
    Neuroendocrinology; 1986 Feb 01; 43(5):597-602. PubMed ID: 3748311
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Progestin effects on prolactin secretion and on immunoreactive prolactin cells in estradiol-treated ovariectomized rats.
    Oliveira MC, Spritzer P, Poy M, Coronel AX, Dahlem N, Moraes JT, Barbosa-Coutinho LM.
    Horm Metab Res; 1993 Nov 01; 25(11):600-2. PubMed ID: 8288167
    [No Abstract] [Full Text] [Related]

  • 31. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
    Carrillo AJ, Doherty PC, Guan XB, Sturtevant JR, Walro DG.
    Endocrinology; 1991 Jan 01; 128(1):131-8. PubMed ID: 1986914
    [Abstract] [Full Text] [Related]

  • 32. Inhibitory effects of exogenously induced hyperprolactinemia on the endogenous cyclic release of luteinizing hormone and prolactin in the estrogen-primed ovariectomized rat.
    Cohen-Becker IR, Selmanoff M, Wise PM.
    Endocrinology; 1986 Oct 01; 119(4):1718-25. PubMed ID: 3757909
    [Abstract] [Full Text] [Related]

  • 33. Effects of xenoestrogen bisphenol A on uterine and pituitary weight, serum prolactin levels and immunoreactive prolactin cells in ovariectomized Wistar rats.
    Goloubkova T, Ribeiro MF, Rodrigues LP, Cecconello AL, Spritzer PM.
    Arch Toxicol; 2000 Apr 01; 74(2):92-8. PubMed ID: 10839476
    [Abstract] [Full Text] [Related]

  • 34. Anti-hyperprolactinemic activities of aqueous extract of Uvaria chamae (P. Beauv) roots and associated biochemical changes in chlorpromazine-induced hyperprolactinemic female Wistar rats.
    Yakubu MT, Fayemo HT.
    J Ethnopharmacol; 2021 May 10; 271():113863. PubMed ID: 33485972
    [Abstract] [Full Text] [Related]

  • 35. Three-dimensional imaging of hormone-secreting cells and their microvessel environment in estrogen-induced prolactinoma of the rat pituitary gland by confocal laser scanning microscopy.
    Itoh J, Kawai K, Serizawa A, Yamamoto Y, Ogawa K, Matsuno A, Watanabe K, Osamura RY.
    Appl Immunohistochem Mol Morphol; 2001 Dec 10; 9(4):364-70. PubMed ID: 11759065
    [Abstract] [Full Text] [Related]

  • 36. Exogenous estradiol enhances apoptosis in regressing post-partum rat corpora lutea possibly mediated by prolactin.
    Goyeneche AA, Telleria CM.
    Reprod Biol Endocrinol; 2005 Aug 30; 3():40. PubMed ID: 16131396
    [Abstract] [Full Text] [Related]

  • 37. D-Trp-6-luteinizing hormone-releasing hormone inhibits hyperprolactinemia in female rats.
    Debeljuk L, Torres-Alemán I, Schally AV.
    Endocrinology; 1985 Jun 30; 116(6):2227-31. PubMed ID: 3158510
    [Abstract] [Full Text] [Related]

  • 38. Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma.
    Shull JD, Spady TJ, Snyder MC, Johansson SL, Pennington KL.
    Carcinogenesis; 1997 Aug 30; 18(8):1595-601. PubMed ID: 9276635
    [Abstract] [Full Text] [Related]

  • 39. Modulation of protein kinases and microtubule-associated proteins and changes in ultrastructure in female rat pituitary cells: effects of estrogen and bromocriptine.
    Matsuno A, Takekoshi S, Sanno N, Utsunomiya H, Ohsugi Y, Saito N, Kanemitsu H, Tamura A, Nagashima T, Osamura RY, Watanabe K.
    J Histochem Cytochem; 1997 Jun 30; 45(6):805-13. PubMed ID: 9199666
    [Abstract] [Full Text] [Related]

  • 40. Prolactin signaling modulates stress-induced behavioral responses in a preclinical mouse model of migraine.
    Mason BN, Kallianpur R, Price TJ, Akopian AN, Dussor GO.
    Headache; 2022 Jan 30; 62(1):11-25. PubMed ID: 34967003
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.